Viking Therapeutics (VKTX) Cooled Down After Strong Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Viking Therapeutics Inc. (VKTX)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Healthcare Stocks to Buy Under $50
According to Michael Adams, the Lead Editor of Investing at Forbes, investments in healthcare stocks provide investors with consistent and steady returns because of the defensive nature of these stocks...
Here’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
Baron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Viking Therapeutics (VKTX) Shares Rose in Q1
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Says You Should Not Buy These 11 Stocks
Jim Cramer in a latest program said the "bulls" want the economy to slow down, they want rate cuts as well as a strong demand so that "their companies" won't have to worry about the yield curve and macroeconomic...
Viking Therapeutics (VKTX) Stock Shot Up After the Release of a Study Report on Injectable Obesity Drug
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
This Biotech Stock is a "Strong Buy" According to Raymond James
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will look at a particular biotech which recently got a "Strong Buy" rating from Raymond James analysts...
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
